Analyzing the Future of Cell & Gene Therapy Manufacturing Services Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Future CAGR of the Cell & Gene Therapy Manufacturing Services Market, and How Will It Impact Industry Expansion?
In the last few years, the cell & gene therapy manufacturing services market has seen significant expansion. It is predicted that this market will increase from $8.15 billion in 2024 to $9.46 billion in 2025, boasting a compound annual growth rate (CAGR) of 16.1%. This substantial growth during the historic period arises from a rise in R&D funding, supportive regulatory frameworks, the expansion of the cell & gene therapy pipeline, collaborations and partnerships within the industry, and a growing worldwide demand for personalized medicine.
The market for cell & gene therapy manufacturing services is anticipated to expand rapidly in the coming years, reaching a market size of $17.97 billion in 2029 with a compound annual growth rate (CAGR) of 17.4%. Several factors such as the maturation and commercialization of the market, the worldwide growth of biopharmaceutical manufacturing, increased reliance on outsourcing by pharmaceutical enterprises, and innovations in automation and robotics can all contribute to this growth during the predicted period. The surge in demand for energy efficiency, sophisticated materials and technologies, streamlined and modular designs, electrification of transportation, and a focus on safety and reliability are expected to shape the major market trends within this forecast period.
How Are the key drivers expanding the growth of the cell & gene therapy manufacturing services Market?
A surge in the occurrence of cancer and other targeted diseases is anticipated to stimulate the expansion of the market for cell and gene therapy manufacturing services. Cancer, a severe condition that leads to the body’s cells multiplying rapidly and unchecked, causes unnatural growth. Rising incidences of cancer are being countered with emerging cell and gene therapies, which are creating a demand for innovative and effective treatment options. To illustrate, the American Cancer Society, an American non-profit cancer advocacy group, reported in January 2023, an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, indicating a rise of 3.16%. Consequently, the increasing prevalence of cancer and other targeted diseases continues to spur the advancement of the cell and gene therapy manufacturing services market.
Get Your Free Sample of the Global Cell & Gene Therapy Manufacturing Services Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp
What Are the Top Market Players Propelling the Growth of the Cell & Gene Therapy Manufacturing Services Industry?
Major companies operating in the cell & gene therapy manufacturing services market include:
• Thermo Fisher Scientific Inc._x000D_
• Merck KGaA_x000D_
• Charles River Laboratories International Inc._x000D_
• Lonza Group AG_x000D_
• Catalent Inc._x000D_
What Are the Key Trends to Watch in the Cell & Gene Therapy Manufacturing Services Market Over the Coming Years?
The cell and gene therapy manufacturing services market is witnessing a trend towards technological innovation. To maintain their market position, leading firms in this sector are integrating cutting-edge technologies. As an example, in October 2022, Charles River Laboratories International Inc., a global pharmaceutical company known for its diverse preclinical and clinical lab, gene therapy, and cell therapy services, introduced the navigation Vector Platform. This platform simplifies the process towards GMP Adeno-Associated Virus (AAV) vector manufacturing, without necessitating significant process development. The navigation platform can potentially reduce the time taken to reach GMP for viral vector gene therapy researchers by 55%, compared to traditional manufacturing processes. The navigation system from Charles River is founded on an exclusive high-yield HEK293 suspension cell line, which can be upscaled and serotyped based on client requirements.
Get Instant Access to the Global Cell & Gene Therapy Manufacturing Services Market Report with Swift Delivery!
Which Growth-Oriented Segments of the Cell & Gene Therapy Manufacturing Services Market Are Leading the Industry’s Development?
The cell & gene therapy manufacturing services market covered in this report is segmented –
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services
What Regions Are Dominating the Cell & Gene Therapy Manufacturing Services Market Growth?
North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Key Characteristics That Define the Cell & Gene Therapy Manufacturing Services Market?
Cell and gene therapy manufacturing services refer to the manufacturing and quality-testing services for gene and cell therapy products. It aids in the advancement and production of remedies for degenerative illnesses, tissue injuries, and genetic abnormalities. These services include good manufacturing practices ancillary reagents, flow cytometry, immunoassays, and gene engineering services.
Browse Through More Similar Reports By The Business Research Company:
Pharmaceutical Drugs And Biologics Logistics Market – By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
Hospital Acquired Infections Testing Kits Global Market Report 2024
COVID-19 Rapid Test Kits Global Market Opportunities And Strategies To 2031
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
